Folate Deficiency

425 Users are discussing this topic

PatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

See also: Folic Acid Deficiency Anaemia written for patients

Folate (folic acid) is one of the B group of vitamins found in small amounts in many foods. Folate is usually absorbed through the upper part of the small intestine. The body's reserves of folate, unlike vitamin B12, are low and only sufficient for around four months.  Almost half of the body folate is found in the liver.

  • Good food sources of folate include broccoli, Brussels sprouts, asparagus, peas, chickpeas and brown rice. Other useful sources include fortified breakfast cereals, beans, some bread and some fruit (such as oranges and bananas).
  • Insufficient folate can result in megaloblastic anaemia. Megaloblastic anaemias are a heterogeneous group of disorders sharing common morphological characteristics. Erythrocytes are larger and have higher nuclear-to-cytoplasmic ratios compared to normoblastic cells. Neutrophils can be hypersegmented and megakaryocytes are abnormal. The maturation of nuclei in megaloblastic cells is delayed while cytoplasmic development is normal.
  • Folate is also required for the development of a healthy fetus and plays an important role in the development of the fetus' spinal cord and brain. There is no simple relationship between maternal folate status and fetal abnormalities but folic acid supplements at the time of conception and in the first 12 weeks of pregnancy reduce the incidence of neural tube defects (NTDs).[1] 
  • Folate is a vital regulator in the metabolic process of homocysteine, which is a risk factor of atherothrombotic events. Low folate intake or low plasma folate concentration is associated with increased cardiovascular and stroke risk.[2] 
  • It may be associated with some types of cancer.[3] 

The main cause of folate deficiency is poor intake, which may occur alone or in combination with excessive utilisation or malabsorption. Folate deficiency can occur for a number of reasons, including:

Dietary deficiency

  • Malabsorption (eg, coeliac disease, tropical sprue, congenital specific malabsorption, jejunal resection, inflammatory bowel disease).
  • Poor intake.
  • Old age.
  • Poor social conditions.
  • Malnutrition.
  • Alcohol excess (also causes impaired utilisation).
  • Poor intake due to anorexia.
  • Food fads.
  • NB: goat's milk has a much lower folate concentration than cow's milk and infants fed exclusively on this may become deficient, unless commercial folic acid-fortified goat's milk is used.

Excessive requirements

Excessive urinary excretion
This includes, for example, congestive heart failure, acute liver damage and chronic dialysis.

Antifolate drugs

  • With uncertain mechanism of action (eg, anticonvulsants and possibly alcohol and nitrofurantoin).
  • Causing malabsorption of folate (eg, colestyramine, sulfasalazine, methotrexate).
  • Trimethoprim may exacerbate pre-existing folate deficiency but does not cause megaloblastic anaemia.

Genetic disorders
Mutations in the SLC46A1 gene, leading to proton-coupled folate transporter deficiency.[4] 

NEW - log your activity

  • Notes
    Add notes to any clinical page and create a reflective diary
  • Track
    Automatically track and log every page you have viewed
  • Print
    Print and export a summary to use in your appraisal
Click to find out more »
  • On a deficient diet, folate deficiency develops over the course of about four months but folate deficiency may develop rapidly in patients who have both a poor intake and excess utilisation of folate.
  • Patients with folate deficiency may be asymptomatic or present with symptoms of anaemia or of the underlying cause.
  • Glossitis can occur.
  • Neurological symptoms (eg, paraesthesia, numbness, cognitive changes, visual disturbance) are more typical of vitamin B12 deficiency but patients with folate deficiency may report mild symptoms of peripheral neuropathy or psychiatric disturbance (eg, depression).
  • FBC and blood film: features of megaloblastic anaemia: the mean corpuscular volume (MCV) is characteristically greater than 96 fL unless there is a co-existing microcytosis when there may be a dimorphic picture with a normal/low average MCV. The peripheral blood film shows macrocytes with hypersegmented polymorphs with six or more lobes in the nucleus. If severe, there may be leukopenia and thrombocytopenia.
  • There is no clear consensus on the level of serum folate that indicates deficiency. Conventionally, clinicians have used serum folate lower than 7 nmol/L (3 lg/L) as a guideline because the risk of megaloblastic anaemia greatly increases below this level.
  • Vitamin B12 levels should be assessed at the same time due to the close relationship in metabolism.
  • Severe folate deficiency can cause pancytopenia as well as megaloblastic anaemia.
  • Both biochemical and clinical evidence of folate deficiency can be observed in the absence of clinical symptoms.
  • The red cell folate level gives an assessment of the tissue folate status over the lifetime of the red cells and is therefore regarded as an indicator of longer-term folate status than the serum folate assay.
  • Red cell folate is assayed by radioisotope dilution or immunological methods. This is to be preferred to serum folate which fluctuates with dietary intake. In about 5% of patients the measurement of red cell folate may be useful in patients with macrocytosis who have a normal serum folate.
  • An erythrocyte folate level less than 340 nmol/L (150 ng/mL) indicates reduced body stores. However, routine red cell folate testing is not necessary because serum folate alone is sufficient in most cases.
  • In many cases of folate deficiency the cause is not obvious from the clinical picture or dietary history. Occult gastrointestinal disease should then be suspected and appropriate investigations, such as small bowel biopsy, should be performed.
  • LFTs, gamma-glutamyl transpeptidase and/or TFTs may be necessary if other causes of macrocytosis such as excessive alcohol intake or hypothyroidism are suspected.
Folic acid may produce a haematological response in vitamin B12 deficiency but may aggravate the neuropathy and also precipitate subacute combined degeneration of the spinal cord. Large doses of folic acid alone should therefore not be used to treat megaloblastic anaemia unless the serum vitamin B12 level is known to be normal.
  • Folate deficiency can be corrected by giving 5 mg of folic acid daily for four months for adults (until term in pregnant women); up to 15 mg daily may be required in malabsorption states. Maintenance is 5 mg every 1-7 days.
  • Any underlying cause - eg, coeliac disease - should be treated.
  • Prophylactic folic acid (400 micrograms daily) is recommended for all women planning a pregnancy.
  • Women who have had a child with an NTD should take 5 mg folic acid daily before and during a subsequent pregnancy.
  • The higher dose of 5 mg during pregnancy is also recommended for the following:
    • Where either partner has an NTD or has already had a pregnancy affected by NTD.
    • Family history of NTD.
    • Anti-epileptic medication.
    • Coeliac disease.
    • Diabetes (type 1 or 2).
    • Thalassaemia trait (5 mg daily until birth of the baby).
    • Haemolytic anaemia, particularly thalassaemia or sickle cell anaemia (5-10 mg until birth of the baby).
    • Women with a BMI >30 kg/m2.
  • For those patients receiving renal dialysis, the prophylactic dose suggested is 5 mg daily to weekly, depending on the diet and rate of haemolysis.
  • Prevention of methotrexate-induced side-effects in rheumatic disease for an adult aged over 18 years: 5 mg once weekly.
  • Prophylactic folic acid is also given in chronic haematological disorders where there is rapid cell turnover (haemolysis): 5 mg every 1-7 days for an adult, depending on underlying disease.

Fortification of food

  • Folic acid fortification in flour is mandatory in the UK to prevent NTDs in babies.
  • Fortification with folic acid has been shown to reduce the prevalence of NTDs in the countries where it has been implemented.[3] 
  • Uncertainty surrounding possible unintended consequences of fortification of food with folic acid has led to concerns about higher folic acid intake and food fortification programmes. This uncertainty emphasises the need to monitor fortification programmes continually, for accurate measures of their effect and the ability to address concerns as they arise.[6] 

Further reading & references

  1. Obican SG, Finnell RH, Mills JL, et al; Folic acid in early pregnancy: a public health success story. FASEB J. 2010 Nov;24(11):4167-74. doi: 10.1096/fj.10-165084. Epub 2010 Jul 14.
  2. Zeng R, Xu CH, Xu YN, et al; The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis. Public Health Nutr. 2015 Jun;18(8):1514-21. doi: 10.1017/S1368980014002134. Epub 2014 Oct 17.
  3. Rautiainen S, Manson JE, Lichtenstein AH, et al; Dietary supplements and disease prevention - a global overview. Nat Rev Endocrinol. 2016 May 6. doi: 10.1038/nrendo.2016.54.
  4. Mahadeo KM, Diop-Bove N, Ramirez SI, et al; Prevalence of a loss-of-function mutation in the proton-coupled folate transporter gene (PCFT-SLC46A1) causing hereditary folate malabsorption in Puerto Rico. J Pediatr. 2011 Oct;159(4):623-7.e1. doi: 10.1016/j.jpeds.2011.03.005. Epub 2011 Apr 13.
  5. Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders; British Committee for Standards in Haematology (2014)
  6. Crider KS, Bailey LB, Berry RJ; Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients. 2011 Mar;3(3):370-84. doi: 10.3390/nu3030370. Epub 2011 Mar 15.

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Colin Tidy
Current Version:
Peer Reviewer:
Dr Hannah Gronow
Document ID:
9216 (v4)
Last Checked:
10/06/2016
Next Review:
09/06/2021

Did you find this health information useful?

Yes No

Thank you for your feedback!

Subcribe to the Patient newsletter for healthcare and news updates.

We would love to hear your feedback!

 
 
Patient Access app - find out more Patient facebook page - Like our page